Cheng Li is a postdoctoral researcher at the Institute for Translational Brain Research at Fudan University. She earned her PhD from the School of Basic Medical Science at Fudan University. Her current research focuses on antibody development and engineering for brain delivery, as well as immunotherapy for brain tumors. Cheng is particularly interested in how cancer cell metabolism interacts with the tumor immune microenvironment in brain tumors. She aims to develop small-sized single-domain brain shuttles to enhance the therapeutic effects of current drugs for brain diseases and improve understanding of brain tumors. Her aspiration is to develop effective treatments for brain metastases.